Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B2 pseudogene 2 (NDUFB2P1)

Target
NDUFB2P1
Molecular classification
Other (pseudogene)
01

Overview

NADH:ubiquinone oxidoreductase subunit B2 pseudogene 2 (NDUFB2P1) is a nonfunctional DNA sequence in the human genome that shares sequence similarity with the functional NDUFB2 gene, which encodes a subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase)[1][4]. As a pseudogene, NDUFB2P1 does not encode a functional protein and is not a viable drug or therapeutic target. Pseudogenes like NDUFB2P1 are typically formed by gene duplication or retrotransposition events and usually lack regulatory elements required for gene expression or contain disabling mutations, such as frameshifts or premature stop codons, preventing production of a normal protein product[4]. While some pseudogenes may be transcribed and influence the expression of their parent genes or have regulatory RNA functions, there is currently no evidence for a direct function, disease association, or therapeutic relevance for NDUFB2P1[1][4]. Similar pseudogenes in the mitochondrial complex I family have been investigated for potential regulatory roles, but these findings have not been established for NDUFB2P1. In summary, NDUFB2P1 is not a druggable or therapeutic target; it is a genomic pseudogene lacking direct biological or pharmacological significance[1][4].

Other names
NDUFB2P1
02

Mechanism of action

None

03

Biological functions

None (Some pseudogenes are transcribed and can regulate their parent gene, but NDUFB2P1 itself does not have a documented biological function)
04

Disease associations

None directly (pseudogenes in general can indirectly play regulatory roles, but no direct disease association is known for NDUFB2P1)

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B2 pseudogene 2 (NDUFB2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B2 pseudogene 2 (NDUFB2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call